Pay in 4 interest-free payments of $6.63 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
Clinical trials so far have shown that injectable GLP-1 drugs, such as Wegovy and Zepbound, remain more effective, particularly in the case of dramatic weight loss
The timing depends on your schedule and when you naturally have light meals available
According to FDA prescribing information, the most frequent gastrointestinal side effects for semaglutide 2.4 mg (Wegovy) include: Nausea (44% of patients) Diarrhea (30% of patients) Vomiting (24% of patients) Constipation (24% of patients) Abdominal pain (20% of patients) Dyspepsia or indigestion (9% of patients) For tirzepatide (Zepbound), similar gastrointestinal effects occur, with rates varying by dose
Tirzepatide for managing overweight and obesity (TA1026): Prescribing, reviewing and stopping tirzepatide
We are committed to helping you access affordable treatment and ensuring you get the care you need without financial stress
